Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Incyte Corporation
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University of Michigan Rogel Cancer Center
University of Chicago
University of Chicago
Thomas Jefferson University
AstraZeneca
University of Chicago
University of Chicago
M.D. Anderson Cancer Center
University Medical Center Groningen
Centre Leon Berard
Stanford University
University of Chicago
Emory University
Presage Biosciences
Bristol-Myers Squibb
Canadian Cancer Trials Group
University of Michigan Rogel Cancer Center
Cantargia AB
University of Chicago
Eastern Cooperative Oncology Group
Tessa Therapeutics
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck KGaA, Darmstadt, Germany
AstraZeneca
University of Michigan Rogel Cancer Center
University of California, Davis
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Groupe Oncologie Radiotherapie Tete et Cou
Celgene
Eli Lilly and Company
Eli Lilly and Company
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
Oncology Institute of Southern Switzerland
University Health Network, Toronto
Groupe Oncologie Radiotherapie Tete et Cou